Light therapy for brain cancer shows promise but trial halted early
NCT ID NCT03897491
First seen Jun 03, 2026 · Last updated Jun 13, 2026 · Updated 3 times
Summary
This study tested a new approach for glioblastoma, an aggressive brain cancer. Doctors injected a light-sensitive drug into the tumor and then activated it with a special laser. The goal was to see if it was safe and could help control the cancer. The trial was stopped early after enrolling only 17 people, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Klinikum der Universität München
München, 81377, Germany
-
Uniklinik Köln
Cologne, 50924, Germany
-
Universitätsklinikum Münster
Münster, 48149, Germany
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.